Pacific Biosciences of California
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $39,766 | $37,153 | $39,224 | $39,967 |
Gross Profit | 14,684 | -363,413 | 10,058 | 10,004 |
EBITDA | -35,575 | -51,861 | 16,393 | -41,088 |
EBIT | -40,157 | -424,640 | 5,444 | -57,187 |
Net Income | -41,930 | -426,075 | 2,371 | -60,725 |
Net Change In Cash | 39,766 | 37,153 | 39,224 | 39,967 |
Free Cash Flow | -24,927 | -50,445 | -32,267 | -44,676 |
Cash | 54,803 | 58,507 | 55,370 | 77,982 |
Basic Shares | 300,162 | 296,858 | 306,892 | 272,915 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $154,014 | $200,521 | $128,304 | $130,513 |
Gross Profit | 37,282 | 52,780 | 49,035 | 58,860 |
EBITDA | -242,785 | -271,125 | -282,240 | -250,757 |
EBIT | -296,136 | -303,816 | -299,558 | -262,342 |
Net Income | -309,851 | -306,735 | -314,248 | -181,223 |
Net Change In Cash | 154,014 | 200,521 | 128,304 | 130,513 |
Cost of Revenue | 379,870 | |||
Free Cash Flow | -212,246 | -268,016 | -280,140 | -117,111 |
Cash | 55,370 | 179,911 | 325,089 | 460,725 |
Basic Shares | 288,366 | 253,629 | 224,550 | 204,136 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.13 |
2025-03-31 | -$0.15 |
2024-12-31 | -$0.20 |
